Everence Capital Management’s AdaptHealth AHCO Stock Holding History

Everence Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,120	Closed	-$141K	–	796
2025 Q4	$141K	Hold	14,120	–	–	0.01%	765
2025 Q3	$126K	Hold	14,120	–	–	0.01%	793
2025 Q2	$133K	Hold	14,120	–	–	0.01%	778
2025 Q1	$153K	Sell	14,120 -2,230	-14%	-$22.4K	0.01%	765
2024 Q4	$156K	Sell	16,350 -9,860	-38%	-$99.8K	0.01%	805
2024 Q3	$294K	Hold	26,210	–	–	0.02%	598
2024 Q2	$258	Hold	26,210	–	–	0.02%	590
2024 Q1	$302	Buy	26,210 +12,160	+87%	+$103K	0.02%	560
2023 Q4	$102K	Buy	+14,050	New	+$111K	0.01%	739
2023 Q3	–	Sell	-11,070	Closed	-$116K	–	739
2023 Q2	$116K	Hold	11,070	–	–	0.01%	711
2023 Q1	$138	Hold	11,070	–	–	0.01%	722
2022 Q4	$213	Buy	+11,070	New	+$234K	0.02%	677

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Everence Capital Management's AHCO Position: Q1 2026 in Review

Everence Capital Management sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 14,120 shares — an estimated $141K sold.

Everence Capital Management first reported a position in AHCO in Q4 2022 and held it in 12 quarters. The position peaked at $294K in Q3 2024. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Everence Capital Management reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 14,120 AdaptHealth shares in Q1 2026, an estimated $141K.
Everence Capital Management first reported a position in AdaptHealth in Q4 2022 and held it in 12 quarters.
Everence Capital Management's AdaptHealth position peaked at $294K in Q3 2024.
241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.